Natalizumab treatment is associated with peripheral sequestration of proinflammatory T cells

Abstract

Natalizumab treatment increases the percentage of activated leukocytes producing proinflammatory cytokines in blood, presumably due to sequestration of activated cells in the peripheral circulation.